Login / Signup

The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis.

Tingting WuXiaotong XiaWenjun ChenJinglan FuJin-Hua Zhang
Published in: Journal of clinical pharmacy and therapeutics (2020)
Patients receiving LMWH anticoagulant therapy to prevent VTE can benefit from anti-Xa monitoring, for which the trough level may be the more appropriate time status to monitor.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • stem cells
  • bone marrow